A61P 19 - Drugs for skeletal disorders

Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2011
12/28/2011	CN102293271A 元素平衡调理茶及其制作工艺 Element balance conditioning and tea production process
12/28/2011	CN102133362B Traditional Chinese medicine composition for treating arthritis
12/28/2011	CN102078464B 祛风活血止疼液 Expelling blood liquid pain
12/28/2011	CN102058747B 一种超微粉碎法制备展筋活血散的工艺 Preparation of ultrafine grinding one kind of muscle blood scattered craft exhibition
12/28/2011	CN102028830B 治疗跌打损伤、骨折、腰椎间盘突出的黑膏药及其制备方法 Treatment of bruises, fractures, lumbar disc black plaster and its preparation method
12/28/2011	CN102000160B 一种具有治疗痛风功能的罗堆多吉颗粒剂及其制备方法 A treatment for gout function Luo heap Dorje granules and its preparation method
12/28/2011	CN101849968B 一种强肾胶囊药物及其制造方法 One kind of drug Qiangshen capsule and its manufacturing method
12/28/2011	CN101810525B 婴幼儿多功能护形保健药枕 Multifunction nursing infant health pillow-shaped
12/28/2011	CN101791288B 一种稳定的来那度胺口服固体制剂 A stable lenalidomide oral solid dosage forms
12/28/2011	CN101766729B 祛湿止痛液及穴敷治疗方法 Dampness and points apply liquid pain treatment
12/28/2011	CN101744951B 腰椎间盘突出康复丸 Lumbar disc rehabilitation pill
12/28/2011	CN101716275B 一种治疗骨髓炎的中成药物及制备方法 A method of treating osteomyelitis of Chinese traditional medicines and preparation methods
12/28/2011	CN101684156B 人TNFα单克隆抗体、其PEG化纳米颗粒及其应用 Human TNFα monoclonal antibody PEG nanoparticles and its application
12/28/2011	CN101549149B 一种新的降钙素的水溶液鼻用喷雾制剂 A new aqueous nasal spray formulation of calcitonin
12/28/2011	CN101524477B 一种治疗颈椎腰椎病的椎骨突出膏 A treatment of cervical lumbar vertebrae prominent cream
12/28/2011	CN101516364B 组合物及其用于治疗、共治疗或预防炎性病症的用途 Use of a composition thereof for the treatment, co-treatment or prevention of inflammatory disorders of the
12/28/2011	CN101164591B 一种祛风除湿药物组合物及其制备方法与用途 One kind Qufengchushi pharmaceutical composition and preparation method and use
12/28/2011	CN101036646B 苦木总生物碱及其单体生物碱的医药用途 Wood bitter alkaloid monomers total alkaloids and medicinal use
12/28/2011	CN101007000B 异黄酮化合物的制药用途以及含有它们的组合物 Isoflavone compounds and pharmaceutical use of the compositions containing them
12/27/2011	US8084645 4-phenylamino-benzaldoxime derivatives and uses thereof as mitogen-activated protein kinase kinase (MEK) inhibitors
12/27/2011	US8084618 Heterocyclic compounds and methods of use
12/27/2011	US8084605 Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
12/27/2011	US8084602 Porphyrin derivatives and their use in photodynamic therapy
12/27/2011	US8084488 Forms of [R-(R,R)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium
12/27/2011	US8084428 Method of repairing meniscal tears
12/27/2011	US8084256 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084253 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease
12/27/2011	US8084049 Complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
12/27/2011	US8084031 Method for the treatment of inflammatory disorders
12/22/2011	WO2011160136A2 Progesterone containing oral dosage forms and related methods
12/22/2011	WO2011159976A2 Arthritis treatment
12/22/2011	WO2011159840A2 Phenylthioacetate compounds, compositions and methods of use
12/22/2011	WO2011159839A2 Thioacetate compounds, compositions and methods of use
12/22/2011	WO2011159124A2 Novel benzoxazole derivative having inhibitory activity against interleukin-6, preparation method thereof, and pharmaceutical composition containing same
12/22/2011	WO2011158931A1 Useful salts of indazole derivative
12/22/2011	WO2011158924A1 Inhibitor of expression of dominant allele
12/22/2011	WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue
12/22/2011	WO2011089531A3 Effects of the association of vitamin k2 and vitamin d3 in the consolidation of a bone fracture
12/22/2011	US20110313055 Health characteristic chewy or gummy candy confection
12/22/2011	US20110313041 Food supplements on the basis of pantothenic acid
12/22/2011	US20110313020 UsiRNA Complexes
12/22/2011	US20110313005 Topically applicable pharmaceutical preparation
12/22/2011	US20110313000 Ccr9 inhibitors and methods of use thereof
12/22/2011	US20110312979 Fused pyrrole derivatives as pi3k inhibitors
12/22/2011	US20110312974 Heteroaryl antagonists of prostaglandin d2 receptors
12/22/2011	US20110312965 Retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
12/22/2011	US20110312964 Cysteine protease inhibitors
12/22/2011	US20110312963 P38 map kinase inhibitors
12/22/2011	US20110312960 Pyrazine derivatives and use as pi3k inhibitors
12/22/2011	US20110312951 C-Ring Modified Tricyclic Benzonaphthiridinone Protein Kinase Inhibitors and Use Thereof
12/22/2011	US20110312950 CYCLIC INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
12/22/2011	US20110312945 Crth2 modulators
12/22/2011	US20110312944 Heterocyclic Compounds Which Modulate The CB2 Receptor
12/22/2011	US20110312936 Cyclohexyl-azetidinyl antagonists of ccr2
12/22/2011	US20110312935 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents
12/22/2011	US20110312928 Progesterone Containing Oral Dosage Forms and Related Methods
12/22/2011	US20110312923 Formulas comprising highly soluble elements and vitamin for the prevention and amelioration of osteoporosis
12/22/2011	US20110312920 Cavity induced allosteric modification of intermolecular interactions and methods of identifying compounds that effect the same
12/22/2011	US20110312906 Treatment or reduction of menopausal symptoms
12/22/2011	US20110312905 Stimulus-triggered prodrugs
12/22/2011	US20110312891 Enamel matrix derivative fraction c
12/22/2011	US20110312887 Promoter for regeneration of tendon-bone junction tissue or ligament-bone junction tissue
12/22/2011	US20110312884 Noggin-Derived Peptide and Use Thereof
12/22/2011	US20110312878 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
12/22/2011	US20110311653 Use of nitrite salts in chronic ischemia
12/22/2011	US20110311652 Novel Saponin Compounds, Methods of Preparation Thereof, Use Thereof and Pharmaceutical Compositions
12/22/2011	US20110311643 Supplemented matrices for the repair of bone fractures
12/22/2011	US20110311637 Methods and medicaments for administration of ibuprofen
12/22/2011	US20110311636 Methods and medicaments for administration of ibuprofen
12/22/2011	US20110311633 Combination of a Silicon Containing Component and a Hormone
12/22/2011	US20110311620 Novel modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
12/22/2011	US20110311592 Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
12/22/2011	US20110311591 Antimicrobial Coating
12/22/2011	US20110311553 Effectors of PAR-2 Activation and Their Use in the Modulation of Inflammation
12/22/2011	US20110311547 Arthritis Treatment
12/22/2011	US20110311546 Angiopoietin-2 specific binding agents
12/22/2011	US20110311538 Inhibitors of receptor tyrosine kinases and methods of use thereof
12/22/2011	US20110311531 Immunotherapy of autoimmune disorders using antibodies which target b-cells
12/22/2011	US20110311529 Method for treating a rheumatic disease using a soluble tla4 molecule
12/22/2011	US20110311526 Polynucleotide and polypeptide sequences involved in the process of bone remodeling
12/22/2011	US20110311519 Methods of treatment of bone degenerative diseases
12/22/2011	US20110311517 Antibodies and methods for treating estrogen receptor-associated diseases
12/22/2011	US20110311507 Methods for Diagnosing and Treating Autoimmune Disorders
12/22/2011	US20110311496 Mesenchymal stem cells and uses therefor
12/22/2011	US20110311491 Treatment of sarcoidosis using placental stem cells
12/22/2011	US20110311487 Delivery of therapeutic agents to the bone
12/22/2011	US20110311485 1,2,4-oxadiazole derivatives and their therapeutic use
12/22/2011	US20110311483 Crth2 modulators
12/22/2011	US20110311449 Antibodies
12/22/2011	CA2825986A1 Arthritis treatment
12/22/2011	CA2805412A1 Therapeutic and cosmetic uses and applications of calreticulin
12/22/2011	CA2802912A1 Innate defence regulatory peptide compositions for treatment of arthritis
12/22/2011	CA2802692A1 Phenylthioacetate compounds, compositions and methods of use
12/22/2011	CA2802535A1 Thioacetate compounds, compositions and methods of use
12/22/2011	CA2802407A1 Treatment of gout and hyperuricemia
12/21/2011	EP2397494A1 Human antibodies that bind human TNFalpha
12/21/2011	EP2397479A1 Hetero ring derivative
12/21/2011	EP2397136A1 Anti-inflammatory composition
12/21/2011	EP1966156B1 New compounds iii
12/21/2011	EP1534290B1 Novel inhibitors of kinases

1 ... 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 ... 820